Yuhong Li
11 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of mFOLFIRINOX as Postoperative Chemotherapy for Pancreatic Cancer in Chinese Patients. (NCT04224402) | Yuhong Li | 2020-01-31 |
| Re-challenge of Anti-EGFR for Patients With RAS/BRAF Wild-type Metastatic CRC (NCT04224415) | Yuhong Li | 2020-01-31 |
Track Yuhong Li automatically
Every clearance here is in the API, with alerts when new ones post.